Xcout IntelClostraBio, Inc. competitors & alternatives
The 12 closest competitors and alternatives to ClostraBio, Inc. among biotech companies — ranked by similarity to what ClostraBio, Inc. actually does, not by market-cap band.
Subscribe to see ClostraBio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ClostraBio, Inc.
ClostraBio, Inc. is a Chicago-based biotechnology research company pioneering microbiome-based solutions, next-generation probiotics for gut health, and advanced metabolite delivery solutions for inflammatory bowel disease.
ClostraBio, Inc. at a glance
ClostraBio, Inc. is a biotech company headquartered in United States. It has raised at least $13.4M across the 2 funding rounds on record. Its most recent funding round raised $9.9M in September 2022. Xcout tracks 6 named people at ClostraBio, Inc., including Ritu Shah (Chief Executive Officer).
ClostraBio, Inc. leadership
- Ritu ShahChief Executive Officer
- Brett NewswangerChief Operating Officer
- Brian MeehanChief Science Officer
- Jeffrey A. HubbellCo-founder, Scientific Advisor & Board Member
- John FlavinBoard Chair
- Scott RavechSenior Strategy Advisor & Board Member
ClostraBio, Inc. funding rounds
At least $13.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $9.9M | — | |
| Seed | $3.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 ClostraBio, Inc. competitors
Ranked by semantic similarity — how close each company is to ClostraBio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
cTRL Therapeutics is a biotechnology research company headquartered in Chicago, Illinois, United States, focused on innovative cellular science and therapeutics.
Biotechnology
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Biotechnology
Notitia Biotechnologies Co develops microbiome-focused products and programs aimed at promoting and restoring the Foundation Guild of gut bacteria for wellness and clinical applications. The company serves patients and the general public seeking to improve their gut health and overall healthspan.
Biotechnology
Codebreaker Bioscience is a privately held bioscience platform startup founded in 2023 that develops microbiome-related solutions and is based in Chile.
Biotechnology
The OpenBiome Foundation expands patient access to microbiome therapies and drives scientific discovery to advance human health. The organization provides resources, strategic collaborations, and investments to equip clinicians, researchers, and healthcare systems with tools for microbiome-directed treatments.
Biotechnology
BiomeBank develops and commercializes microbiome therapeutics designed to restore gut ecological complexity and treat human diseases. The company offers regulated donor-derived therapies, such as BIOMICTRA for recurrent Clostridioides difficile infections, and is advancing a pipeline of next-generation co-cultured microbial products for conditions spanning immunology, metabolism, and oncology. It serves medical practitioners and patients by providing clinically informed gut health treatments.
Similar biotech company
Pendulum Therapeutics is a biotechnology company headquartered in San Francisco, California. Founded by scientific experts, it develops next-generation microbiome products and probiotic solutions to improve metabolic health.
Biotechnology
MRM Health NV is a clinical-stage biopharmaceutical company that develops microbiome-based live biotherapeutic products for the treatment of chronic inflammatory diseases and to augment immune-oncology therapies. Founded in 2019 as a spin-off from the Flanders Institute for Biotechnology (VIB) and Ghent University. MRM Health is developing MH002, a microbial consortium candidate for the treatment of ulcerative colitis, and operates a proprietary co-fermentation platform CORAL.
Biotechnology
Adventa Bioscience Inc. is a biotech firm that develops health and wellness products based on human milk. Its flagship product, Trulacta, is a daily dietary supplement containing Human Milk Bionutrients designed to support gastrointestinal and whole-body health.
Biotechnology
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Life Sciences
Vedanta Biosciences, Inc. is headquartered in Cambridge, Massachusetts, and develops groundbreaking microbiome-derived immunotherapies and therapeutics to improve patient lives.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ClostraBio, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ClostraBio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →